Brez internetne povezave — prikazana je shranjena različica strani.

Equillium Inc

USUSD
← Na Filter Delnic
US:EQLSE:0A4D

Equillium Inc (US:EQ) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 2. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
equilliumbio.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
LA JOLLA, United States
Izvršni Direktor
Bruce Steel
Zaposleni
14
Delnice v Obtoku
63.41 mio. na dan 2026-08-07
Prosto Prenosljive Delnice
36.97 mio.
Tržna Kapitalizacija
89.41 mio. USD
Notranje Osebe
16%
Institucionalni Vlagatelji
65.76%
Panoga (SIC)
Pharmaceutical Preparations
FCF
−20.1 mio. USD
Dolg
7.64 mio. USD
neto denar
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
Opis

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksEQ glavnaUSD1.44 +3.60%navadne delnice
LSE London Stock Exchange0A4D IOBUSD1.4 +0.00%navadne delnice

Cena v 3 Mesecih

dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Novice Ta Teden

Sporočila za javnost s spletne strani za vlagatelje podjetja, ki se dnevno posodabljajo. Povezave vodijo na spletno stran podjetja. Naslovi so v izvirnem jeziku, kot na spletni strani podjetja.

oglas

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Jupiter Topco LLC10.24%6.49 mio.2026-06-30
Decheng Capital LLC7.01%4.45 mio.2026-06-30
Affinity Asset Advisors,…6.47%4.1 mio.2026-06-30
Adar1 Capital Management…5.93%3.76 mio.2026-06-30
Aberdeen Group plc5.73%3.63 mio.2026-06-30
abrdn Life Sciences Inve…5.73%3.63 mio.2026-06-30
Woodline Partners LP5.52%3.5 mio.2026-06-30
RA Capital Management, L…4.88%3.1 mio.2026-06-30
Stempoint Capital LP3.18%2.02 mio.2026-06-30
Vanguard Capital Managem…2.87%1.82 mio.2026-06-30
Eversept Partners, LP2.4%1.52 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.21%1.4 mio.2026-06-30
CONNELLY STEPHEN (Presid…≈1.2%762 0252026-06-05
VANGUARD INDEX FUNDS-Van…0.54%344 4892026-06-30
Fidelity Concord Street…0.26%162 8512026-07-31
iShares Trust-iShares Mi…0.24%153 0762026-08-31
American Century ETF Tru…0.12%75 4112026-08-31
ZEDELMAYER CHRISTINE (Ch…≈0.1%62 5862026-06-05
Fidelity Concord Street…0.09%54 6772026-07-31
Fidelity Concord Street…0.07%47 4652026-07-31
Invesco Exch-Trd Fd. TRT…0.06%38 5162026-08-31
Fidelity Concord Street…0.06%36 6832026-07-31
TOM PENNY (Officer)—02026-05-28
KEYES JASON A (Chief Fin…——2025-01-23